Status:
COMPLETED
Posterior Tibial Transcutaneous Neurostimulation in Idiopathic Overactive Bladder
Lead Sponsor:
Hopital Nord Franche-Comte
Conditions:
Overactive Bladder
Eligibility:
FEMALE
18+ years
Brief Summary
Overactive bladder is a clinical diagnosis affecting up to 17% of women. The existing medical treatment, anticholinergics, has many side effects and is sometimes ineffective. Neurostimulation of the p...
Eligibility Criteria
Inclusion
- Patients treated for overactive bladder
- Patients using the TENSI+ for at least 3 months
Exclusion
- Neurological disease that may explain overactive bladder
- Patient having received anticholinergic drug treatment during neurostimulation.
- Have one or more contraindications to wearing the device: pacemaker, defibrillator, wearing a mechanical implant near the electrode placement area, ankle joint problems, damaged skin, cognitive impairment.
Key Trial Info
Start Date :
March 29 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 17 2024
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06484023
Start Date
March 29 2024
End Date
June 17 2024
Last Update
July 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Nord Franche-Comté
Trévenans, France